BioPharma Lykos CEO to depart after FDA rejection, layoffs By - 0 47 FacebookTwitterPinterestWhatsApp The departure of Amy Emerson as CEO comes three weeks after the MDMA developer revealed plans to cut 75% of its staff. Source link